A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes

Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia

(2010) M W Harr et al.   CELL DEATH AND DIFFERENTIATION

Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias

(2010) B. S. Guerrouahen et al.   CLINICAL CANCER RESEARCH

Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR–ABL, as effectively as in parental sensitive counterparts

(2010) Huseyin Atakan Ekiz et al.   Hematology

The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells

(2010) Zeynep Cakir et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer

(2010) Jiannong Li et al.   Nature Chemical Biology

Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts

(2010) Y-C Lee et al.   ONCOGENE

Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling

(2009) Jyoti Nautiyal et al.   CANCER LETTERS

Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells

(2008) E Bonhoure et al.   LEUKEMIA